These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22335186)

  • 1. The Impact of Medicare's lifetime immunosuppression coverage on racial disparities in kidney graft survival.
    Page TF; Woodward RS; Brennan DC
    Am J Transplant; 2012 Jun; 12(6):1519-27. PubMed ID: 22335186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Income-related disparities in kidney transplant graft failures are eliminated by Medicare's immunosuppression coverage.
    Woodward RS; Page TF; Soares R; Schnitzler MA; Lentine KL; Brennan DC
    Am J Transplant; 2008 Dec; 8(12):2636-46. PubMed ID: 19032227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of lifetime immunosuppression coverage for kidney transplant recipients.
    Page TF; Woodward RS
    Health Care Financ Rev; 2008; 30(2):95-104. PubMed ID: 19361119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of extended coverage of immunosuppressive medications by medicare on the survival of cadaveric renal transplants.
    Woodward RS; Schnitzler MA; Lowell JA; Spitznagel EL; Brennan DC
    Am J Transplant; 2001 May; 1(1):69-73. PubMed ID: 12095042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients.
    Taber DJ; Gebregziabher M; Payne EH; Srinivas T; Baliga PK; Egede LE
    Transplantation; 2017 Feb; 101(2):402-410. PubMed ID: 26901080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.
    Yen EF; Hardinger K; Brennan DC; Woodward RS; Desai NM; Crippin JS; Gage BF; Schnitzler MA
    Am J Transplant; 2004 Oct; 4(10):1703-8. PubMed ID: 15367228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors.
    Butkus DE; Meydrech EF; Raju SS
    N Engl J Med; 1992 Sep; 327(12):840-5. PubMed ID: 1508243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Racial and Ethnic Disparities in Access to Care and Health Among US Adults at Age 65 Years.
    Wallace J; Jiang K; Goldsmith-Pinkham P; Song Z
    JAMA Intern Med; 2021 Sep; 181(9):1207-1215. PubMed ID: 34309621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.
    Page TF; Woodward RS
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):435-44. PubMed ID: 19817527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis.
    Nee R; Jindal RM; Little D; Ramsey-Goldman R; Agodoa L; Hurst FP; Abbott KC
    Transplantation; 2013 Jun; 95(12):1471-8. PubMed ID: 23680929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and ethnic disparities in pediatric renal allograft survival in the United States.
    Patzer RE; Mohan S; Kutner N; McClellan WM; Amaral S
    Kidney Int; 2015 Mar; 87(3):584-92. PubMed ID: 25337773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients.
    Taber DJ; Douglass K; Srinivas T; McGillicuddy JW; Bratton CF; Chavin KD; Baliga PK; Egede LE
    Am J Nephrol; 2014; 40(1):19-28. PubMed ID: 24969370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.
    Taber DJ; Hunt KJ; Fominaya CE; Payne EH; Gebregziabher M; Srinivas TR; Baliga PK; Egede LE
    Hypertension; 2016 Sep; 68(3):715-25. PubMed ID: 27402921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.
    Kadatz M; Gill JS; Gill J; Formica RN; Klarenbach S
    J Am Soc Nephrol; 2020 Jan; 31(1):218-228. PubMed ID: 31704739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients.
    Taber DJ; Gebregziabher M; Srinivas T; Egede LE; Baliga PK
    Ann Transplant; 2018 Feb; 23():119-128. PubMed ID: 29449524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation.
    Luan FL; Kommareddi M; Cibrik DM; Samaniego M; Ojo AO
    Am J Transplant; 2010 Sep; 10(9):2074-81. PubMed ID: 20645942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with long-term graft survival in pediatric kidney transplant recipients.
    Anand A; Malik TH; Dunson J; McDonald MF; Christmann CR; Galvan NTN; O'Mahony C; Goss JA; Srivaths PR; Brewer ED; Rana A
    Pediatr Transplant; 2021 Jun; 25(4):e13999. PubMed ID: 33704871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis.
    Palanisamy AP; Schiltz CE; Pilch NA; Hunt KJ; Nadig SN; Dowden JE; McGillicuddy JW; Baliga PK; Chavin KD; Taber DJ
    Blood Press; 2015 Feb; 24(1):14-22. PubMed ID: 25048253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.